Teachers Advisors’s Corvus Pharmaceuticals CRVS Stock Holding History

Teachers Advisors’s Portfolio CRVS Stock Details CRVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$90K	Hold	22,433	–	–	﹤0.01%	2942
2018 Q4	$82K	Hold	22,433	–	–	﹤0.01%	2967
2018 Q3	$192K	Sell	22,433 -163	-0.7%	-$1.63K	﹤0.01%	2949
2018 Q2	$248K	Buy	22,596 +7,028	+45%	+$78.5K	﹤0.01%	2937
2018 Q1	$179K	Hold	15,568	–	–	﹤0.01%	2903
2017 Q4	$161K	Hold	15,568	–	–	﹤0.01%	2967
2017 Q3	$248K	Hold	15,568	–	–	﹤0.01%	2920
2017 Q2	$188K	Buy	15,568 +12,017	+338%	+$128K	﹤0.01%	3018
2017 Q1	$74K	Hold	3,551	–	–	﹤0.01%	3011
2016 Q4	$51K	Hold	3,551	–	–	﹤0.01%	3055
2016 Q3	$58K	Hold	3,551	–	–	﹤0.01%	3039
2016 Q2	$51K	Buy	+3,551	New	+$48K	﹤0.01%	3073

Other funds holding CRVS

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

ASP

Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Cowen Inc New York $1.39B AUM 60.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Teachers Advisors's CRVS Position: Q1 2019 in Review

Teachers Advisors held its Corvus Pharmaceuticals (CRVS) position steady in Q1 2019 at 22,433 shares worth $90K. The position accounts for ﹤0.01% of the portfolio, ranked #2942.

Teachers Advisors first reported a position in CRVS in Q2 2016 and has held it in 12 quarters since. The position peaked at $248K in Q2 2018. 58 funds tracked by Wall St. Rank hold CRVS as of Q1 2019.

Teachers Advisors held 22,433 shares of Corvus Pharmaceuticals worth $90K as of Q1 2019.
Teachers Advisors left its Corvus Pharmaceuticals share count unchanged in Q1 2019.
Corvus Pharmaceuticals made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2942 holding.
Teachers Advisors first reported a position in Corvus Pharmaceuticals in Q2 2016 and has held it in 12 quarters since.
Teachers Advisors's Corvus Pharmaceuticals position peaked at $248K in Q2 2018.
58 funds tracked by Wall St. Rank held Corvus Pharmaceuticals as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.